Navigation Links
eMetagens infectious disease technology licensed by WARF

MADISON - eMetagen announced Monday it has completed a license agreement with the Wisconsin Alumni Research Foundation to commercialize technology developed by Robert Goodman and collaborators at the University of Wisconsin-Madison over the past nine years.

Founded by Goodman, a UW profes......

Full article >>> 8,520 STTR Grant from the National Institutes of Health in March. The grant will fund research to find novel anti-bioweapon compounds in eMetagens natural product libraries. The company will begin operations at the McAllen T.E.C. Incubator on May 15th, 2004.

As a winner of the UW Business Schools Burrill Competition in 2001, Copaescu reflected on how the experience affected her work for ......

Full article >>>
'"/> By WTN News 05/05/04

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Stem cells produce anti-disease protein in brain experiment
3. Neurognostics pushes early prediction of brain disease
4. ZyStor receives first funding and buys theraputics for rare diseases
5. Thompsons HHS legacy will include efforts to combat disease in Africa
6. Predictive medicine: Genes indicate diseases before symptoms do
7. FDA approves Bone Cares Hectorol for treatment of kidney disease
8. Symposium examines the effect of race on genetics and disease
9. HotMasterAn innovative Hot Start/Cold Stop technology for better PCR* results
10. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
11. GOP, Dems split over funding of state technology projects
Post Your Comments:

(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 /PRNewswire/ ... ), a biotechnology company developing bioengineered organ implants for ... will present at the LD Micro "Main Event" ... p.m. PT. The presentation will be webcast live and ... will also be available at the conference for one-on-one ...
(Date:11/25/2015)... 25, 2015 The Global ... a professional and in-depth study on the current ... (Logo: ) , The ... including definitions, classifications, applications and industry chain structure. ... international markets including development trends, competitive landscape analysis, ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... Nov. 24, 2015  Clintrax Global, Inc., a worldwide provider of ... , today announced that the company has set a new quarterly ... quarter on quarter growth posted for Q3 of 2014 to Q3 ... Mexico , with the establishment of an ... --> United Kingdom and ...
Breaking Biology Technology:
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
Breaking Biology News(10 mins):